Valuation: Becton, Dickinson and Company

Market Cap 4.91TCr 88TCr 4.38TCr 4.09TCr 3.72TCr 7TCr 4,74700Cr 7.05TCr 49TCr 19TCr 2,41400Cr 18TCr 18TCr 7,76100Cr P/E 2026 *
34.7x
P/E 2027 * 19.4x
Enterprise Value 6.5TCr 1,17000Cr 5.8TCr 5.41TCr 4.92TCr 9.26TCr 6,28400Cr 9.33TCr 65TCr 25TCr 3,19600Cr 24TCr 24TCr 10,27300Cr EV / Sales 2026 *
3.37x
EV / Sales 2027 * 3.19x
Free-Float
73.18%
Yield 2026 *
2.18%
Yield 2027 * 2.22%
1 day+4.31%
6 months-4.15%
Current year-24.08%
Current year 2,498.49
Extreme 2498.49
3,093.03
1 year 2,498.49
Extreme 2498.49
3,535.21
3 years 2,498.49
Extreme 2498.49
4,843.41
5 years 2,498.49
Extreme 2498.49
5,784.37
10 years 2,498.49
Extreme 2498.49
6,405.1
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Chief Tech/Sci/R&D Officer 56 04/12/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+4.31%-.--% - - 4.91TCr
+0.58%-0.10%-25.78%+1.91% 17TCr
-1.81%-0.90%-13.04%+12.34% 11TCr
-1.01%+0.00%-25.41%+3.59% 11TCr
-0.03%+0.72%-46.94%-10.61% 7.6TCr
+0.28%+5.66%+2.77%+72.56% 6.04TCr
-0.40%+6.30%+11.13%+65.94% 5.35TCr
-0.08%+0.65%-6.42%-31.35% 4.91TCr
-1.70%-2.97%-19.23%+13.61% 4.06TCr
+1.09%-2.31%+27.67%+1.30% 3.15TCr
Average +0.54%+0.25%-10.58%+14.36% 7.77TCr
Weighted average by Cap. +0.55%-0.04%-16.55%+11.79%

Financials

2026 *2027 *
Net sales 1.93TCr 35TCr 1.72TCr 1.61TCr 1.46TCr 2.75TCr 1,86500Cr 2.77TCr 19TCr 7.54TCr 95TCr 7.24TCr 7.08TCr 3,04900Cr 1.97TCr 36TCr 1.76TCr 1.65TCr 1.49TCr 2.81TCr 1,90900Cr 2.84TCr 20TCr 7.72TCr 97TCr 7.41TCr 7.25TCr 3,12200Cr
Net income 143.66Cr 2.59TCr 128.36Cr 119.76Cr 108.78Cr 204.87Cr 14TCr 206.4Cr 1.44TCr 562.24Cr 7.07TCr 539.34Cr 527.67Cr 23TCr 233.95Cr 4.21TCr 209.03Cr 195.02Cr 177.14Cr 333.62Cr 23TCr 336.12Cr 2.34TCr 915.59Cr 12TCr 878.3Cr 859.3Cr 37TCr
Net Debt 1.59TCr 29TCr 1.42TCr 1.32TCr 1.2TCr 2.27TCr 1,53700Cr 2.28TCr 16TCr 6.22TCr 78TCr 5.96TCr 5.83TCr 2,51200Cr 1.4TCr 25TCr 1.25TCr 1.16TCr 1.06TCr 1.99TCr 1,35000Cr 2TCr 14TCr 5.46TCr 69TCr 5.24TCr 5.12TCr 2,20700Cr
Projected Income Statement - Annual - Becton, Dickinson and Company
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Becton, Dickinson and Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
180.16USD
Average target price
194.08USD
Spread / Average Target
+7.72%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Becton, Dickinson and Company